Welcome to the Desert Angels. We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies. The organization serves only as a forum for its over 70 members, who invest individually from their personal funds. Since 2000, Desert Angel members have invested over $10 million in more than 40 presenting companies.

Portfolio Companies

amplimed

Amplimed Corporation

AmpliMed Corporation, a clinical-stage cancer pharmaceutical company founded by world-renowned oncologists, has a lead compound, Amplimexon®, in Phase II clinical trials, with early evidence of effectiveness and low levels of toxicity. Disease targets include pancreatic cancer, lung cancer and melanoma.
biovidria

BioVidria

bioVidria, Inc. is focused on developing and manufacturing a wide variety of labware used in genetics research based on a novel and proprietary surface technology. This technology can be applied to microarrays, multi-well plates, and other labware critical to research conducted in both corporate and academic laboratories.
biovigilan

BioVigilant

BioVigilant Systems invented instantaneous microbial detection technology to address environmental monitoring needs in pharmaceutical, biotechnology, healthcare, and environmental applications. BioVigilant’s IMD systems detect—instantaneously and in real time—particulate count, size, and biological status.
boom

Carb-BOOM

Carbboom Nutrition Inc. produces and markets sport nutrition products geared towards endurance athletes. We are committed to serving the athletes with the best ingredients and the best tasting products. All of our products do not contain anything artificial. Our premium fruit flavored gels are make with real fruits purees and concentrates.
cellzdirect

CellzDirect

Now part of the Invitrogen family, CellzDirect provides high-quality in vitro ADME cell products and contract laboratory and consulting services focused primarily on drug metabolism and transport. With CellzDirect’s support, scientists conduct research that accelerates the discovery of safe and effective drugs.
htg

HTG

High Throughput Genomics (HTG) was founded in 1997 with the mission to develop a universal molecular biology-based platform to improve the pharmaceutical drug discovery process. Since that time, HTG has expanded the utility of qNPA™ technology into the fields of gene expression profiling, Translational Medicine and Diagnostic applications and the measurement of miRNA.
lipoint

Lipoint

LiPoint Inc. is a development stage biopharmaceutical company focused on rapid acting therapies for acute medical conditions such as pain, and hormonal imbalances. Initially our technology is useful for nasal drug delivery however it can also be applied for other mucosal routes of administration.
medipacs

Medipacs

Headquartered in San Diego, California, Medipacs is focused on commercializing the first non-mechanical infusion pump based on a new, expandable polymer. The Medipacs novel polymer technology enables drug infusion pumps are that are wearable, programmable and disposable to allow for greater accuracy, patient comfort and convenience at a lower cost.
microblend

Microblend

Welcome to MicroBlend Technologies. Our innovation is redefining paint – its quality, color, and dependability. We’re changing the way you think about paint. Our patented Automated Paint Machine™ (APM™) system dispenses on demand, at your location, a full-spectrum of interior and exterior latex paints and primers in multiple quality grades, in all sheen levels, in all colors and sizes.
playbilitytoys

Play Ability Toys

PlayAbility Toys is THE source of fun, unique toys that are developmentally appropriate for all young children and in particular children with special needs! The company specifically designs and markets toys that have many sensory features that incorporate auditory, tactile, visual and motor stimulation.
regenesisbio

Regenesis

Regenesis Biomedical Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant® Therapy System, indicated for the palliative treatment of post-operative pain and edema in superficial soft tissue.
syncardia

SynCardia Systems

SynCardia Systems, Inc. is a private company formed in 2001 to commercialize the SynCardia temporary CardioWest™ Total Artificial Heart. Today, with more than 800 implants, the SynCardia Total Artificial Heart is the only FDA, Health Canada and CE approved Total Artificial Heart in the world.
Tempronics_logo

Tempronics

Based on research that started in Oak Ridge National Labs, our devices employ a physical phenomenon called “thermotunneling” that promises to convert heat to electricity more efficiently and affordably than any existing means. It will also provide cleaner and quieter cooling for a wide variety of applications.